RICHMOND, Calif. (AP) — RICHMOND, Calif. (AP) — Sangamo Therapeutics Inc. (SGMO) on Monday reported a loss of $37.4 million in its fourth quarter.
The Richmond, California-based company said it had a loss of 11 cents per share. Losses, adjusted for asset impairment costs, were 7 cents per share.
The drug developer posted revenue of $14.2 million in the period.
For the year, the company reported a loss of $122.9 million, or 44 cents per share. Revenue was reported as $39.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
